FDA approves Arbel Medical's cryotherapy device

01/2/2008 | Globes (Israel)

The FDA has given its general approval for Arbel Medical to market its IceSense probe, a minimally invasive cryotherapy device for the removal of benign and malignant tumors. The Israel-based company plans to launch the product in 2009 and to seek specific approvals to use the device in removing breast and uterine tumors.

View Full Article in:

Globes (Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN